Proud Sponsor of the Organization of Women in International Trade - Badge

Antitrust Lawyer Blog

DOJ Issues Second Request over AT&T, BellSouth
Doyle, Barlow & Mazard PLLC

On May 2, AT&T Inc. (“AT&T”) and BellSouth Corp. (“BellSouth”) confirmed that the DOJ had issued a second request with respect to AT&T’s nearly $90 billion acquisition of BellSouth. This transaction will make AT&T the dominant phone carrier in 22 states and comes on the heels of two other large telecom deals and amid growing…

Continue reading ›
FCC Commissioner Tate Speaks on Revamping Telecom Act
Doyle, Barlow & Mazard PLLC

Speaking to the Tennessee Telecommunications Association on May 2, FCC Commissioner Deborah T. Tate said that any revamping of the 1996 Telecommunications Act should include language that permits the government to play a limited role in creating fair rules, while allowing the marketplace to drive industry development and innovation in such areas as broadband and…

Continue reading ›
FTC Approves Publication of New Rules for Telemarketing Fees
Doyle, Barlow & Mazard PLLC

Also on April 28, the Commission approved the publication of a notice of proposed rulemaking in the Federal Register that would amend the Telemarketing Sales Rule to revise the fees charged for industry access to the National Do Not Call Registry. The FTC is currently accepting comments on these proposed fee changes. Under the proposed…

Continue reading ›
FTC Urges FDA to Clear Uncertainty over Whole Grain Food Statements
Doyle, Barlow & Mazard PLLC

On April 28, the Federal Trade Commission (“Commission”) authorized the staffs of the Bureau of Consumer Protection, Bureau of Economics and Office of Policy Planning to file comments with the U.S. Food and Drug Administration (“FDA”) concerning the FDA’s recently issued draft guidance for industry and agency staff on labeling statements about the whole grain…

Continue reading ›
Comments over Whole Grain Labeling
Doyle, Barlow & Mazard PLLC

On April 28, the Federal Trade Commission (“Commission”) authorized the staffs of the Bureau of Consumer Protection, Bureau of Economics and the Office of Policy Planning to file comments with the U.S. Food and Drug Administration (“FDA”) concerning the FDA’s recently issued draft guidance for industry and agency staff on labeling statements about the whole…

Continue reading ›
FTC Revises Fees for Do Not Call Registry
Doyle, Barlow & Mazard PLLC

On April 28, the Federal Trade Commission approved the publication of a notice of proposed rulemaking in the Federal Register that would amend the Telemarketing Sales Rule to revise the fees charged for industry access to the National Do Not Call Registry. The FTC is currently accepting comments on these proposed fee changes. Under the…

Continue reading ›
Fifth Annual International Competition Network Conference
Doyle, Barlow & Mazard PLLC

On April 27, the DOJ announced that Assistant Attorney General Thomas O. Barnett will participate in the fifth annual International Competition Network (“ICN”) Conference in Cape Town, South Africa, on May 3-5, 2006. At the conference, senior antitrust officials and private antitrust experts from around the world as well as representatives from intergovernmental organizations will…

Continue reading ›
Carmel Concrete to Pay Fines
Doyle, Barlow & Mazard PLLC

On April 27, the DOJ announced Hughey Inc., which does business as Carmel Concrete Products (“Carmel”), and its president, Scott D. Hughey agreed to plead guilty and pay criminal fines for fixing the price of ready mixed concrete in the Indianapolis metropolitan area. Under the plea agreement, which must be approved by the court, Carmel…

Continue reading ›
FTC Releases Sumary of Agreements by Branded Drug Manufacturers
Doyle, Barlow & Mazard PLLC

On April 24th, the Federal Trade Commission’s Bureau of Competition issued a summary of agreements filed with the Commission in fiscal year 2005 (ending September 30, 2005) by generic and branded drug manufacturers. The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 requires drug companies to file certain agreements with the FTC and the…

Continue reading ›
Concent Agreement Issued over Boston Scientific – Guidant Merger
Doyle, Barlow & Mazard PLLC

On April 20th, the Federal Trade Commission announced a consent agreement that will protect competition and consumers in several significant medical device markets affected by Boston Scientific’s proposed $27 billion acquisition of the Guidant Corporation (“Guidant”). The agreement will allow the transaction to proceed, provided the parties comply fully with its terms.Under the terms of…

Continue reading ›
Aerial view of Washington DC cityscape from Arlington Virginia USA.

Contact Us

Fill out the form or call us at (202) 589-1834 to schedule your consultation.